CYTOKINETICS INC (CYTK)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

-35M 0 35M 70M 105M Q1 '10: 622K Q2 '10: 462K Q3 '10: 394K Q4 '10: 1.1M Q1 '11: 763K Q2 '11: 1.1M Q3 '11: 1.4M Q4 '11: 757K Q1 '12: 1.8M Q2 '12: 1.8M Q3 '12: 1.7M Q4 '12: 2.2M Q1 '13: 821K Q2 '13: 1M Q3 '13: 4.5M Q4 '13: 24.3M Q1 '14: 8M Q2 '14: 7.8M Q3 '14: 9.4M Q4 '14: 21.8M Q1 '15: 4.4M Q2 '15: 6.5M Q3 '15: 7.9M Q4 '15: 9.8M Q1 '16: 8.4M Q2 '16: 5.8M Q3 '16: 59M Q4 '16: 33.1M Q1 '17: 4.2M Q2 '17: 3.1M Q3 '17: 6.2M Q4 '17: -18K Q1 '18: 5.3M Q2 '18: 6.2M Q3 '18: 10.6M Q4 '18: 9.4M Q1 '19: 8.5M Q2 '19: 7.1M Q3 '19: 6.1M Q4 '19: 5.2M Q1 '20: 3.8M Q2 '20: 3.6M Q3 '20: 41.7M Q4 '20: 6.7M Q1 '21: 6.5M Q2 '21: 2.8M Q3 '21: 5.4M Q4 '21: 55.6M Q1 '22: 1.1M Q2 '22: 89M Q3 '22: 2.5M Q4 '22: 2M Q1 '23: 4.6M Q2 '23: 867K Q3 '23: 378K Q4 '23: 1.7M Q1 '24: 835K Q2 '24: 249K Q3 '24: 463K Q4 '24: 16.9M Q1 '25: 1.6M Q2 '25: 66.8M Q3 '25: 1.9M Q4 '25: 17.8M Q1 '26: 19.4M Q2 '26: 28.6M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-210M -140M -70M 0 70M 140M 210M Q1 '10: -12.3M Q2 '10: -13.2M Q3 '10: -12.6M Q4 '10: -11.6M Q1 '11: -11.8M Q2 '11: -13.6M Q3 '11: -10.7M Q4 '11: -11.9M Q1 '12: -9.9M Q2 '12: -9M Q3 '12: -10.1M Q4 '12: -11.5M Q1 '13: -12.6M Q2 '13: -15.1M Q3 '13: -12.6M Q4 '13: 6.4M Q1 '14: -8.8M Q2 '14: -8.4M Q3 '14: -6M Q4 '14: 8.4M Q1 '15: -8.9M Q2 '15: -10.6M Q3 '15: -8.9M Q4 '15: -9M Q1 '16: -12M Q2 '16: -11M Q3 '16: 34M Q4 '16: 7.7M Q1 '17: -23.3M Q2 '17: -25.2M Q3 '17: -28.4M Q4 '17: -36.5M Q1 '18: -26.1M Q2 '18: -23.4M Q3 '18: -17.9M Q4 '18: -21.5M Q1 '19: -24.5M Q2 '19: -26.7M Q3 '19: -23.9M Q4 '19: -23.7M Q1 '20: -30.4M Q2 '20: -32.4M Q3 '20: 5.2M Q4 '20: -36.4M Q1 '21: -40.6M Q2 '21: -54.8M Q3 '21: -69.2M Q4 '21: -21.7M Q1 '22: -77.9M Q2 '22: -10.9M Q3 '22: -108.4M Q4 '22: -127M Q1 '23: -124.5M Q2 '23: -122M Q3 '23: -122.3M Q4 '23: -127.4M Q1 '24: -126.2M Q2 '24: -130.2M Q3 '24: -140.8M Q4 '24: -139M Q1 '25: -155.6M Q2 '25: -111.5M Q3 '25: -166.8M Q4 '25: -178.4M Q1 '26: -183.6M Q2 '26: -179.2M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Net Income Quarterly

-450M -300M -150M 0 150M 300M 450M Q1 '10: -12.2M Q2 '10: -13.1M Q3 '10: -12.3M Q4 '10: -11.6M Q1 '11: -11.7M Q2 '11: -13.6M Q3 '11: -10.6M Q4 '11: -11.9M Q1 '12: -9.9M Q2 '12: -8.9M Q3 '12: -10M Q4 '12: -11.5M Q1 '13: -12.6M Q2 '13: -15M Q3 '13: -12.6M Q4 '13: 6.5M Q1 '14: -8.7M Q2 '14: -8.4M Q3 '14: -6M Q4 '14: 8.4M Q1 '15: -8.9M Q2 '15: -10.6M Q3 '15: -8.8M Q4 '15: -9.2M Q1 '16: -12.5M Q2 '16: -11.6M Q3 '16: 33.4M Q4 '16: 7.2M Q1 '17: -25.9M Q2 '17: -29.1M Q3 '17: -32.4M Q4 '17: -40.5M Q1 '18: -30.3M Q2 '18: -27.5M Q3 '18: -22M Q4 '18: -26.5M Q1 '19: -29.4M Q2 '19: -32.1M Q3 '19: -29.6M Q4 '19: -30.6M Q1 '20: -39.4M Q2 '20: -40.8M Q3 '20: -3.2M Q4 '20: -43.9M Q1 '21: -47.1M Q2 '21: -61.6M Q3 '21: -76.1M Q4 '21: -30.6M Q1 '22: -89.4M Q2 '22: -19.8M Q3 '22: -142.3M Q4 '22: -137.4M Q1 '23: -131.3M Q2 '23: -128.6M Q3 '23: -129.4M Q4 '23: -136.9M Q1 '24: -135.6M Q2 '24: -143.3M Q3 '24: -160.5M Q4 '24: -150M Q1 '25: -161.4M Q2 '25: -134.4M Q3 '25: -306.2M Q4 '25: -183M Q1 '26: -206M Q2 '26: -198.8M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-180M -120M -60M 0 60M 120M 180M Q3 '10: -10.3M Q4 '10: -9.1M Q1 '11: -12.9M Q2 '11: -12.5M Q3 '11: -9.3M Q4 '11: -10.9M Q1 '12: -8.7M Q2 '12: -8.7M Q3 '12: -8.9M Q4 '12: -7.1M Q1 '13: -12.2M Q2 '13: 6.6M Q3 '13: 10.3M Q4 '13: -12.4M Q1 '14: -17.8M Q2 '14: -9.4M Q3 '14: -9.5M Q4 '14: -8.1M Q1 '15: 34.4M Q2 '15: -9.2M Q3 '15: -10.3M Q4 '15: -9.9M Q1 '16: -17.5M Q2 '16: -11.2M Q3 '16: -12.1M Q1 '17: -20.9M Q2 '17: -31.3M Q3 '17: -25.5M Q4 '17: -24.1M Q1 '18: -29.8M Q2 '18: -26.8M Q3 '18: -32.2M Q4 '18: -12.3M Q1 '19: -26.9M Q2 '19: -24.7M Q3 '19: -20.3M Q4 '19: -19.1M Q1 '20: -30.1M Q2 '20: -27.4M Q3 '20: 14.4M Q4 '20: 52.1M Q1 '21: -29.5M Q2 '21: -29.5M Q3 '21: -38.8M Q4 '21: -44.7M Q1 '22: -26.8M Q2 '22: -90.5M Q3 '22: -84M Q4 '22: -98.2M Q1 '23: -122.3M Q2 '23: -121.8M Q3 '23: -96.2M Q4 '23: -74M Q1 '24: -129.5M Q2 '24: -99.3M Q3 '24: -101.5M Q4 '24: -65.6M Q1 '25: -131.6M Q2 '25: -128.2M Q3 '25: -107.5M Q4 '25: -142.7M Q1 '26: -145.5M Q2 '26: -159.8M Q1 '12 Q1 '14 Q1 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow Quarterly

-180M -120M -60M 0 60M 120M 180M Q3 '10: -10.4M Q4 '10: -9.2M Q1 '11: -13.1M Q2 '11: -12.6M Q3 '11: -9.4M Q4 '11: -11M Q1 '12: -8.8M Q2 '12: -8.7M Q3 '12: -8.9M Q4 '12: -7.2M Q1 '13: -12.4M Q2 '13: 6.6M Q3 '13: 10.2M Q4 '13: -12.7M Q1 '14: -18.2M Q2 '14: -9.8M Q3 '14: -9.6M Q4 '14: -8.4M Q1 '15: 34.2M Q2 '15: -9.4M Q3 '15: -10.4M Q4 '15: -10.1M Q1 '16: -17.9M Q2 '16: -11.2M Q3 '16: -12.4M Q1 '17: -22.3M Q2 '17: -31.5M Q3 '17: -25.9M Q4 '17: -24.9M Q1 '18: -30.1M Q2 '18: -26.9M Q3 '18: -32.6M Q4 '18: -12.5M Q1 '19: -27.2M Q2 '19: -24.7M Q3 '19: -21.3M Q4 '19: -20.4M Q1 '20: -31.2M Q2 '20: -28.3M Q3 '20: 11.8M Q4 '20: 45.6M Q1 '21: -36.1M Q2 '21: -38.3M Q3 '21: -54.5M Q4 '21: -62.5M Q1 '22: -27.8M Q2 '22: -91.3M Q3 '22: -90.4M Q4 '22: -101.4M Q1 '23: -122.7M Q2 '23: -122.5M Q3 '23: -96.4M Q4 '23: -74.1M Q1 '24: -129.5M Q2 '24: -101.2M Q3 '24: -102.2M Q4 '24: -66.9M Q1 '25: -137.3M Q2 '25: -132.4M Q3 '25: -116.9M Q4 '25: -148.3M Q1 '26: -151.4M Q2 '26: -164.2M Q1 '12 Q1 '14 Q1 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q3 '15: 38.8M Q3 '16: 43.2M Q3 '17: 53.7M Q2 '21: 71.8K Q3 '21: 80.3K Q1 '22: 85K Q2 '22: 85.7K Q3 '22: 93.8K Q1 '23: 95.2K Q2 '23: 95.8K Q3 '23: 96.1K Q1 '24: 101.9K Q2 '24: 109.2K Q3 '24: 117.7K Q1 '25: 118.5K Q2 '25: 119.5K Q3 '25: 120K Q1 '26: 123.3K Q2 '26: 132.1K Q3 '15 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q4 '10: -0.77 Q1 '11: -0.76 Q2 '11: -0.78 Q3 '11: -0.74 Q4 '11: -4.31 Q1 '12: -4.26 Q2 '12: -4.79 Q3 '12: -5.09 Q4 '12: -1.78 Q1 '13: -2.18 Q2 '13: -2.00 Q3 '13: -1.98 Q4 '13: -1.24 Q1 '14: -0.98 Q2 '14: -0.63 Q3 '14: -0.36 Q4 '14: -0.41 Q1 '15: -0.37 Q2 '15: -0.41 Q3 '15: -0.48 Q4 '15: -0.97 Q1 '16: -1.05 Q2 '16: -1.07 Q3 '16: -0.07 Q4 '16: 0.33 Q1 '17: 0.02 Q2 '17: -0.29 Q3 '17: -1.66 Q4 '17: -2.59 Q1 '18: -2.53 Q2 '18: -2.44 Q3 '18: -2.24 Q4 '18: -1.95 Q1 '19: -1.93 Q2 '19: -1.98 Q3 '19: -2.08 Q4 '19: -2.11 Q1 '20: -2.23 Q2 '20: -2.35 Q3 '20: -1.90 Q4 '20: -2.02 Q1 '21: -2.02 Q1 '12 Q3 '13 Q1 '15 Q3 '16 Q1 '18 Q3 '19 Q1 '21

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.